Keywords: Ipsen, Financial results, Third-quarter 2012

Ipsen posts 5% sales growth for 3rd-qtr 2012

Article | 29 October 2012

French drugmaker Ipsen (Euronext: IPN) yesterday reported third-quarter 2012 financial results with 5% growth in group sales to 294.9 million euros ($381.4 million), with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Ipsen

Go to company listing